Risk of acute pancreatitis with carbimazole use (MHRA Drug Safety Update)
The MHRA has released a Drug Safety Update about the risk of acute pancreatitis with the use of products containing carbimazole and thiamazole.
If acute pancreatitis occurs during treatment with ca
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Pancreatitis